Global ENT Surgical Energy Device Market Size, Share, & COVID-19 Impact Analysis 2023-2029 - MedCore - Includes: Capital Equipment and Radiofrequency (RF) and Ultrasonic Probes

The global market for ENT surgical energy devices had a valuation of $479.3 million in 2022. It is projected to grow at a CAGR of 1.9% during the forecast period and reach $545.8 million. The comprehensive report covers capital equipment, as well as radiofrequency (RF) and ultrasonic probes used in ENT surgery.

MARKET DATA INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2029, and Historical Data to 2019
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

GLOBAL ENT SURGICAL ENERGY DEVICE MARKET INSIGHTS

The primary factor driving the ENT surgical energy device market is the level of precision these devices provide during ENT procedures. The probes create highly accurate lines of demarcation, which has led many physicians to prefer using these devices during operations on their patients.

GLOBAL ENT SURGICAL ENERGY DEVICE MARKET SHARE INSIGHTS

The Global ENT surgical energy device market was led by Smith & Nephew, Olympus, and Ethicon.

Smith & Nephew was the leading company in the ENT surgical energy device market in 2022, as it was the only major player in the market that did not offer both RF and ultrasonic energy-based devices. Its flagship product line, Coblation™, utilizes bipolar RF energy with the aid of a conductive medium. The company typically provides its generator for free when customers purchase probes, which allows it to generate most of its revenue and market share in the RF and ultrasonic probe segment.

MARKET SEGMENTATION SUMMARY

ENT Surgical Energy Device Market - MedCore - Includes:

• Capital Equipment, Radiofrequency (RF) and Ultrasonic Probes.

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
• Base Year: 2022
• Forecast Period: 2023-2029
• Historical Data: 2019-2022
• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.